{"log_id": 5235103199711377074, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0.011711, "average": 0.956359, "min": 0.476946}, "location": {"width": 940, "top": 155, "height": 26, "left": 133}, "words": "妊娠妇女服用替加环素可能引起胎儿毒性。替加环素对人鼠或家兔无致畸作用。临床前安全性矿究发"}, {"probability": {"variance": 0.001605, "average": 0.99043, "min": 0.726291}, "location": {"width": 981, "top": 203, "height": 28, "left": 93}, "words": "现,C标记的替加环素能通过胎盘进入胎儿组织,包括胎儿骨骼结构。以AUC计算,大鼠和家兔的替加"}, {"probability": {"variance": 0.000579, "average": 0.990778, "min": 0.866306}, "location": {"width": 980, "top": 252, "height": 28, "left": 92}, "words": "环素暴露量分别处于5倍和1倍于人每日剂量与胎鼠或胎兔体重的轻度减轻以及未成年动物骨骼异常(骨"}, {"probability": {"variance": 7.2e-05, "average": 0.995913, "min": 0.950895}, "location": {"width": 767, "top": 300, "height": 28, "left": 92}, "words": "化延迟)相关。家兔暴露于等同于人类剂量的母体毒性剂量时,死胎的发生率增加"}, {"probability": {"variance": 0.001325, "average": 0.985531, "min": 0.809402}, "location": {"width": 938, "top": 349, "height": 28, "left": 136}, "words": "尚未有在妊娠妇女中进行关于替加环素的、足够的、对照良好的研究。本品只有在对胎儿的潜在利益"}, {"probability": {"variance": 4e-06, "average": 0.998852, "min": 0.991209}, "location": {"width": 385, "top": 398, "height": 26, "left": 94}, "words": "超过潜在风险时才可考虑在妊娠期间使用"}, {"probability": {"variance": 9e-06, "average": 0.996884, "min": 0.991152}, "location": {"width": 103, "top": 447, "height": 24, "left": 136}, "words": "哺乳期妇女"}, {"probability": {"variance": 0.005, "average": 0.980482, "min": 0.56623}, "location": {"width": 937, "top": 491, "height": 27, "left": 138}, "words": "应用14C标记的替加环素进行动物研究,结果提示替加环素易于经泌乳大鼠的乳汁分泌。替加环素口服"}, {"probability": {"variance": 8e-06, "average": 0.998608, "min": 0.983337}, "location": {"width": 849, "top": 538, "height": 30, "left": 94}, "words": "生物利用度有限,与此一致的是,哺乳小狗经母乳喂养获得的替加环素全身暴露量微乎其微"}, {"probability": {"variance": 6e-06, "average": 0.998406, "min": 0.991285}, "location": {"width": 828, "top": 583, "height": 31, "left": 136}, "words": "尚不清楚本品是否经人乳分泌。因为许多药物经人乳分泌,所以本品应用于乳母时应谨慎"}, {"probability": {"variance": 7e-06, "average": 0.998271, "min": 0.992632}, "location": {"width": 116, "top": 634, "height": 27, "left": 100}, "words": "【儿童用药】"}, {"probability": {"variance": 0.002174, "average": 0.990138, "min": 0.723341}, "location": {"width": 691, "top": 681, "height": 27, "left": 140}, "words": "18岁以下患者的疗效及安全性尚不明确。因此,不推荐用于18岁以下患者"}, {"probability": {"variance": 0.003486, "average": 0.989563, "min": 0.598433}, "location": {"width": 936, "top": 729, "height": 27, "left": 134}, "words": "牙齿发育阶段(怀孕后半期、婴几期和8岁前儿童期)使用治疗可能造成永久性的牙齿变色(棕黄色)"}, {"probability": {"variance": 3.9e-05, "average": 0.99751, "min": 0.973837}, "location": {"width": 348, "top": 777, "height": 27, "left": 92}, "words": "因此,不推荐8岁以下儿童使用本品"}, {"probability": {"variance": 1e-06, "average": 0.999079, "min": 0.997}, "location": {"width": 117, "top": 826, "height": 26, "left": 99}, "words": "【老年用药】"}, {"probability": {"variance": 2.4e-05, "average": 0.99807, "min": 0.967555}, "location": {"width": 937, "top": 872, "height": 28, "left": 136}, "words": "在Ⅲ期临床试验共2514名接受本品治疗的患者中,65岁及以上共664名,75岁及以上共288名。这"}, {"probability": {"variance": 2e-06, "average": 0.999374, "min": 0.991782}, "location": {"width": 980, "top": 919, "height": 29, "left": 94}, "words": "些老年患者在总体安全性或疗效上与年轻患者相比无意料之外的差异,但不能除外一些老年患者更容易出"}, {"probability": {"variance": 4e-06, "average": 0.998431, "min": 0.99436}, "location": {"width": 107, "top": 971, "height": 26, "left": 93}, "words": "现不良事件"}, {"probability": {"variance": 0.01088, "average": 0.961285, "min": 0.556446}, "location": {"width": 940, "top": 1017, "height": 28, "left": 135}, "words": "健康老年受试者和年轻受试者给予单剂量10mg的替加环素后,试验结果显示替加环素暴露量没有显"}, {"probability": {"variance": 1.8e-05, "average": 0.996707, "min": 0.989309}, "location": {"width": 85, "top": 1068, "height": 25, "left": 95}, "words": "著性差异"}, {"probability": {"variance": 1e-06, "average": 0.999112, "min": 0.997697}, "location": {"width": 161, "top": 1114, "height": 27, "left": 100}, "words": "【药物相互作用】"}, {"probability": {"variance": 3e-06, "average": 0.998646, "min": 0.993958}, "location": {"width": 343, "top": 1160, "height": 29, "left": 136}, "words": "只对成年人进行了药物相互作用研究"}, {"probability": {"variance": 7.5e-05, "average": 0.996535, "min": 0.942661}, "location": {"width": 939, "top": 1208, "height": 28, "left": 136}, "words": "在药物相互作用研究中,同时给予健康受试者本品(首剂100mg,然后每12小时50mg)和地高辛(首"}, {"probability": {"variance": 0.002692, "average": 0.979088, "min": 0.740035}, "location": {"width": 980, "top": 1256, "height": 30, "left": 94}, "words": "剂0.5mg继之0.5mg口服,每24小时一次),替加环素能使地高辛的Cmx轻度降低13%A对地高辛的"}, {"probability": {"variance": 0.000894, "average": 0.985333, "min": 0.849763}, "location": {"width": 981, "top": 1302, "height": 32, "left": 95}, "words": "AUC或清除率并无影响。以ECG间期改变作为衡量标准,Cm的轻度改变并未影响地高辛的稳态药效学效"}, {"probability": {"variance": 0.022282, "average": 0.930259, "min": 0.377889}, "location": {"width": 954, "top": 1353, "height": 38, "left": 94}, "words": "应。另外,地高辛不影响替加环素的药代动力学特性。因此,本品与地高辛合用时两囊案整剂量"}, {"probability": {"variance": 0.009729, "average": 0.973284, "min": 0.420081}, "location": {"width": 938, "top": 1401, "height": 34, "left": 135}, "words": "健康受试者同时应用本品(首剂100mg,然后每12小时50mg)和华法令单剂4可导致R"}, {"probability": {"variance": 0.008776, "average": 0.97672, "min": 0.401763}, "location": {"width": 862, "top": 1448, "height": 30, "left": 95}, "words": "华法令和S-华法令的清除率分别减少40%和23%,Cma分别升高38%和43%,AUC分别增加"}, {"probability": {"variance": 0, "average": 0.999024, "min": 0.999024}, "location": {"width": 19, "top": 1450, "height": 20, "left": 1001}, "words": "和"}, {"probability": {"variance": 0.000534, "average": 0.993017, "min": 0.854618}, "location": {"width": 968, "top": 1494, "height": 32, "left": 95}, "words": "替加环素未显著改变华法令对INR的影响。另外,华法令未对替加环素的药代动力学特性造成影响。然而"}, {"probability": {"variance": 0.000981, "average": 0.992353, "min": 0.818803}, "location": {"width": 677, "top": 1544, "height": 29, "left": 95}, "words": "替加环素与华法令合并用药应该监测凝血酶原时间或其他合适的抗凝试验"}, {"probability": {"variance": 0.003547, "average": 0.932787, "min": 0.873232}, "location": {"width": 19, "top": 1577, "height": 20, "left": 565}, "words": "10"}], "language": 3}